Table 1 Cohort baseline characteristics
From: The Chronic Kidney Disease Model: A General Purpose Model of Disease Progression and Treatment
Variable Description | CKD Stage 1 | CKD Stage 2 | CKD Stage 3 | CKD Stage 4 | CKD Stage 5 | Data Sources |
|---|---|---|---|---|---|---|
Male | 65.80% | 56.5% | 37.8% | 35.9% | 35.9% | [19] |
White race | 39.5% | 48% | 47.5% | 43.5% | 20% | [19] |
Age 20-30 | 55.1% | 16% | 1.90% | 1.50% | 0% | [19] |
Age 40-59 | 25.1% | 34% | 4.8% | 1.5% | 5% | [19] |
Age 60-69 | 10.1% | 23% | 23.2% | 30.2% | 10% | [19] |
Age > 69 | 9.70% | 27% | 69.70% | 66.80% | 85% | [19] |
CKD stage | 30.3% | 27.2% | 39.0% | 2.6% | 1.5% | [19] |
Proteinuria | 14.3% | 14.3% | 6.1% | 42.6% | NA | [1] |
Diabetes | 18.9% | 22.1% | 16.9% | 17.1% | 17.1% | [20] |
Hypertension | 24.1% | 35.3% | 46.5% | 51.6% | 94% | [19] |
Calcium/Phosphorous abnormalities | 3% | 15% | 50% | 70% | 85% | [21] |
Pre-existing Cardiovascular disease | 10% | 12.9% | 17.6% | 25% | 60% | [17] |